Aerovate Therapeutics Stock Quote AVTE - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

25.30

Bid

11.00

Ask

40.22

Volume

0.00 Day's Range 0.00

9.41 52 Week Range 32.415

Market Cap

700.023M

Previous Close

25.30

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

145,895

Shares Outstanding

27,668,887

Dividend Yield

PE Ratio

-9.27

Earnings Per Share (EPS)

-2.73

Revenue

Net Profit

-75.52M

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aerovatetx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $25.30. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 9.41 to $ 32.415.

Aerovate Therapeutics currently has 27,668,887 shares outstanding. The market capitalization of Aerovate Therapeutics is $700.02 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -9.27.

Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference

WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.11	-4.20295342673	26.41	28.7	24.27	147468	26.60597814	CS
4	-0.77	-2.95358649789	26.07	32.415	24.27	210515	27.60721058	CS
12	4.8	23.4146341463	20.5	32.415	16.74	145895	24.20971047	CS
26	14.33	130.628988149	10.97	32.415	9.41	107675	21.25826205	CS
52	8.3	48.8235294118	17	32.415	9.41	94143	19.09809341	CS
156	-2.7	-9.64285714286	28	32.415	7.74	98193	18.49064261	CS
260	-2.7	-9.64285714286	28	32.415	7.74	98193	18.49064261	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DYNTDynatronics Corp	$ 0.7129 (92.47%)	5.92M
DFLIDragonfly Energy Holdings Corporation	$ 0.7099 (57.76%)	4.57M
WISAWiSA Technologies Inc	$ 2.68 (53.14%)	3.65M
MCBCMacatawa Bank Corporation	$ 13.71 (38.07%)	29.93k
LXEOLexeo Therapeutics Inc	$ 14.95 (23.66%)	652
RVYLRYVYL Inc	$ 1.25 (-39.35%)	21.46k
ALPPAlpine 4 Holdings Inc	$ 0.5111 (-30.93%)	1
DRMADermata Therapeutics Inc	$ 0.22 (-26.72%)	946.14k
INOInovio Pharmaceuticals Inc New	$ 8.32 (-24.29%)	5.34k
AIHAesthetic Medical International Holdings Group Ltd	$ 0.3029 (-23.34%)	3
KXINKaixin Holdings	$ 0.18 (20.00%)	10.78M
DYNTDynatronics Corp	$ 0.7129 (92.47%)	5.92M
SPCBSuperCom Ltd	$ 0.4916 (22.78%)	5.85M
DFLIDragonfly Energy Holdings Corporation	$ 0.7099 (57.76%)	4.57M
WISAWiSA Technologies Inc	$ 2.68 (53.14%)	3.65M